Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M707463200 on February 7, 2008

J. Biol. Chem., Vol. 283, Issue 16, 10543-10549, April 18, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/16/10543    most recent
M707463200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, S. H.
Right arrow Articles by Blumberg, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, S. H.
Right arrow Articles by Blumberg, P. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Characterization of the Interaction of Phorbol Esters with the C1 Domain of MRCK (Myotonic Dystrophy Kinase-related Cdc42 Binding Kinase) {alpha}*Formula

Sung Hee Choi{ddagger}, Gabriella Czifra{ddagger}, Noemi Kedei{ddagger}, Nancy E. Lewin{ddagger}, Jozsef Lazar{ddagger}, Yongmei Pu{ddagger}, Victor E. Marquez§, and Peter M. Blumberg{ddagger}1

From the {ddagger}Laboratory of Cancer Biology and Genetics, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892 and §Laboratory of Medicinal Chemistry, Center for Cancer Research, NCI-Frederick, National Institutes of Health, Frederick, Maryland 21701

C1 domains mediate the recognition and subsequent signaling response to diacylglycerol and phorbol esters by protein kinase C (PKC) and by several other families of signal-transducing proteins such as the chimerins or RasGRP. MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase), a member of the dystrophia myotonica protein kinase family that functions downstream of Cdc42, contains a C1 domain with substantial homology to that of the diacylglycerol/phorbol ester-responsive C1 domains and has been reported to bind phorbol ester. We have characterized here the interaction of the C1 domains of the two MRCK isoforms {alpha} and β with phorbol ester. The MRCK C1 domains bind [20-3H]phorbol 12,13-dibutyrate with Kd values of 10 and 17 nM, respectively, reflecting 60–90-fold weaker affinity compared with the protein kinase C {delta} C1b domain. In contrast to binding by the C1b domain of PKC{delta}, the binding by the C1 domains of MRCK {alpha} and β was fully dependent on the presence of phosphatidylserine. Comparison of ligand binding selectivity showed resemblance to that by the C1b domain of PKC{alpha} and marked contrast to that of the C1b domain of PKC{delta}. In intact cells, as in the binding assays, the MRCK C1 domains required 50–100-fold higher concentrations of phorbol ester for induction of membrane translocation. We conclude that additional structural elements within the MRCK structure are necessary if the C1 domains of MRCK are to respond to phorbol ester at concentrations comparable with those that modulate PKC.


Received for publication, September 6, 2007 , and in revised form, February 7, 2008.

* This work was supported by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.

1 To whom correspondence should be addressed: Laboratory of Cancer Biology and Genetics, NCI, National Institutes of Health, Bldg. 37, Rm. 4048B, 37 Convent Dr., MSC 4255, Bethesda, MD 20892-4255. Tel.: 301-496-3189; Fax: 301-496-8709; E-mail: blumberp{at}dc37a.nci.nih.gov.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Pu, S. H. Garfield, N. Kedei, and P. M. Blumberg
Characterization of the Differential Roles of the Twin C1a and C1b Domains of Protein Kinase C{delta}
J. Biol. Chem., January 9, 2009; 284(2): 1302 - 1312.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Colon-Gonzalez, F. C. Leskow, and M. G. Kazanietz
Identification of an Autoinhibitory Mechanism That Restricts C1 Domain-mediated Activation of the Rac-GAP {alpha}2-Chimaerin
J. Biol. Chem., December 12, 2008; 283(50): 35247 - 35257.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wen, W. Liu, J. Yan, and M. Zhang
Structure Basis and Unconventional Lipid Membrane Binding Properties of the PH-C1 Tandem of Rho Kinases
J. Biol. Chem., September 19, 2008; 283(38): 26263 - 26273.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement